URIDINE TRIACETATE for Chemotherapy toxicity attenuation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 56 adverse event reports in the FDA FAERS database where URIDINE TRIACETATE was used for Chemotherapy toxicity attenuation.
Most Reported Side Effects for URIDINE TRIACETATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Complication associated with device | 20 | 18.2% | 2 | 1 |
| Diarrhoea | 19 | 17.3% | 4 | 4 |
| Vomiting | 19 | 17.3% | 4 | 5 |
| Off label use | 14 | 12.7% | 1 | 2 |
| Thrombocytopenia | 10 | 9.1% | 4 | 5 |
| Nausea | 9 | 8.2% | 4 | 3 |
| Neutropenia | 9 | 8.2% | 6 | 5 |
| Hypokalaemia | 8 | 7.3% | 0 | 0 |
| Inappropriate schedule of product administration | 8 | 7.3% | 3 | 0 |
| Mucosal inflammation | 7 | 6.4% | 3 | 3 |
| Death | 6 | 5.5% | 6 | 0 |
| Stomatitis | 5 | 4.6% | 0 | 4 |
Other Indications for URIDINE TRIACETATE
Other Drugs Used for Chemotherapy toxicity attenuation
LEUCOVORIN (38)
LEVOLEUCOVORIN (32)
METHYLPREDNISOLONE (27)
ONDANSETRON (16)
FILGRASTIM (7)
FOLIC ACID (7)
CYANOCOBALAMIN (6)
APREPITANT (5)